LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT BETWEEN AIT THERAPEUTICS, INC. AND CIRCASSIA LIMITEDLicense, Development and Commercialization Agreement • February 14th, 2019 • AIT Therapeutics, Inc. • Surgical & medical instruments & apparatus • Delaware
THIS LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (this “Agreement”) is made and entered into effective as of January 23, 2019 (the “Effective Date”), by and between AIT Therapeutics, Inc., a Delaware corporation having its principal place of business at 825 East Gate Blvd. Garden City, NY 11530 (“AIT Therapeutics”), and Circassia Limited, a company registered in England and Wales, Company number 03689966, with a registered office at The Magdalen Centre, Robert Robinson Avenue, Science Park, Oxford OX4 4GA, United Kingdom (“Circassia”). Each of AIT Therapeutics and Circassia is sometimes referred to herein as a “Party” and collectively, as the “Parties.”
